Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1977 Feb;126(2):143–147.

Allopurinol-hypersensitivity vasculitis and liver damage.

T D Boyer, N Sun, T B Reynolds
PMCID: PMC1237483  PMID: 139760

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerbach R., Orentrich N. Alopecia and ichthyosis secondary to allopurinol. Arch Dermatol. 1968 Jul;98(1):104–104. doi: 10.1001/archderm.98.1.104b. [DOI] [PubMed] [Google Scholar]
  2. Elion G. B., Yü T. F., Gutman A. B., Hitchings G. H. Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am J Med. 1968 Jul;45(1):69–77. doi: 10.1016/0002-9343(68)90008-9. [DOI] [PubMed] [Google Scholar]
  3. Greenberg M. S., Zambrano S. S. Aplastic agranulocytosis after allopurinol therapy. Arthritis Rheum. 1972 Jul-Aug;15(4):413–416. doi: 10.1002/art.1780150413. [DOI] [PubMed] [Google Scholar]
  4. Greene M. L., Fujimoto W. Y., Seegmiller J. E. Urinary xanthine stones--a rare complications of allopurinol therapy. N Engl J Med. 1969 Feb 20;280(8):426–427. doi: 10.1056/NEJM196902202800806. [DOI] [PubMed] [Google Scholar]
  5. Jarzobski J., Ferry J., Wombolt D., Fitch D. M., Egan J. D. Vasculitis with allopurinol therapy. Am Heart J. 1970 Jan;79(1):116–121. doi: 10.1016/0002-8703(70)90401-1. [DOI] [PubMed] [Google Scholar]
  6. Kantor G. L. Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy. JAMA. 1970 Apr 20;212(3):478–479. [PubMed] [Google Scholar]
  7. Mills R. M., Jr Severe hypersensitivity reactions associated with allopurinol. JAMA. 1971 May 3;216(5):799–802. [PubMed] [Google Scholar]
  8. Ogryzlo M. A., Urowitz M. B., Weber H. M., Houpt J. B. The treatment of gout and disorders of uric acid metabolism with allopurinol. Can Med Assoc J. 1966 Nov 26;95(22):1120–1127. [PMC free article] [PubMed] [Google Scholar]
  9. Rundles R. W., Metz E. N., Silberman H. R. Allopurinol in the treatment of gout. Ann Intern Med. 1966 Feb;64(2):229–258. doi: 10.7326/0003-4819-64-2-229. [DOI] [PubMed] [Google Scholar]
  10. Scott J. T., Hall A. P., Grahame R. Allopurinol in treatment of gout. Br Med J. 1966 Aug 6;2(5509):321–327. doi: 10.1136/bmj.2.5509.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Simmons F., Feldman B., Gerety D. Granulomatous hepatitis in a patient receiving allopurinol. Gastroenterology. 1972 Jan;62(1):101–104. [PubMed] [Google Scholar]
  12. Stratigos J. D., Bartsokas S. K., Capetanakis J. Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives. Br J Dermatol. 1972 Jun;86(6):564–567. doi: 10.1111/j.1365-2133.1972.tb05070.x. [DOI] [PubMed] [Google Scholar]
  13. Young J. L., Jr, Boswell R. B., Nies A. S. Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise. Arch Intern Med. 1974 Sep;134(3):553–558. doi: 10.1001/archinte.134.3.553. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES